CLINICAL_TRIALS
research
· 2025-09-17
Clinical Trial Update: Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5 [NA]
Summary
This clinical trial update describes monitoring hyperkalemia in chronic kidney disease patients (stages 3b-5) using a point-of-care AI-enabled ECG device; the s…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Peking University First Hospital | Conditions: Chronic Kidney Disease (Stages 3b-5) | NA | Status: RECRUITING